*Note: exact level depending on experience*
Company Overview:
Vividion is a next generation biotechnology company based in San Diego that is leveraging its proprietary chemical proteomics platform to conduct proteome-wide footprinting of drug-protein interactions with unprecedented breadth and precision. Our technology allows us to screen, identify and optimize novel drugs that selectively bind virtually any protein, including proteins previously considered “undruggable”. Our pipeline and emerging programs reflect a matured and productive platform capable of delivering first in class drugs utilizing novel mechanisms of action (allosteric inhibitors, protein-protein interaction inhibitors, functional activators, degraders etc.) against undruggable targets in the oncology and immunology space.
We prize scientific excellence, creativity, team players and we are committed to continued innovation. We have worked hard to create a collaborative and dynamic work culture where your ideas and discoveries are valued and will have an impact. We are growing and there are opportunities for mentorship and career progression.
Vividion has been recognized as a Top Workplace by The San Diego Union-Tribune from 2022 to 2025.
Job Summary:
We are seeking a very highly motivated, collaborative biotransformation expert who is passionate and dedicated to using DMPK expertise to drive drug discovery and development programs at Vividion. The Biotransformation position will be responsible for all aspects of metabolite profiling, identification and associated enzymology of select projects. This position will be part of the Biotransformation group and will provide the opportunity to take on additional Biotransformation responsibilities for the broader Vividion portfolio.
This position has both technical and broader scientific advisory aspects including providing scientific and strategic input, guiding medicinal chemists in chemical series optimization, problem-solving and cross-functional collaboration, and innovation in a team environment. The successful candidate will design, execute, and manage in vitro soft-spot and tox species selection MetID studies, and definitive in vivo MetID studies. This role involves both experimental laboratory-based work and management of biotransformation studies conducted at CRO’s. The successful candidate is expected to be well-versed in the interpretation of mass spectra, and proficient in the preparation of data summaries, presentation of results to project teams and management, authoring regulatory reports, and contributing to regulatory documents to support clinical development.
Job details are sourced from the employer's original posting.
Open job postingAbout the company
Vividion Therapeutics is a biopharmaceutical company focused on the discovery and development of novel therapeutics for cancer and other diseases. They utilize a proprietary chemoproteomic platform to identify and drug previously undruggable targets.